Status and phase
Conditions
Treatments
About
By improved kidney dosimetry including biological effective dose and taking into account potential risk factors (especially for kidney toxicity), it might be possible to give an optimal and personalized treatment with 177Lu-DOTA-TATE to the patient with metastatic neuroendocrine tumor.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Step 1:
Step 2:
Exclusion criteria
Step 1:
Step 2:
Primary purpose
Allocation
Interventional model
Masking
60 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal